Author:
Kleemann Elke,Schmehl Thomas,Gessler Tobias,Bakowsky Udo,Kissel Thomas,Seeger Werner
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference62 articles.
1. H. Olschewski and W. Seeger. Pulmonary Hypertension: Pathophysiology, Diagnosis, Treatment, and Development of a Pulmonary-Selective Therapy, UNI-MED Verlag AG, Bremen, 2002.
2. S. Archer and S. Rich. Primary pulmonary hypertension: a vascular biology and translational research “work in progress”. Circulation 102:2781–2791 (2000).
3. D. B. Badesch, S. H. Abman, G. S. Ahearn, R. J. Barst, D. C. McCrory, G. Simonneau, and V. V. McLaughlin. Medical therapy for pulmonary arterial hypertension—ACCP evidence-based clinical practice guidelines. Chest 126:35S–62S (2004).
4. R. T. Schermuly, C. Inholte, H. A. Ghofrani, H. Gall, N. Weissmann, A. Weidenbach, W. Seeger, and F. Grimminger. Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors. Respir. Res. 6:76 (2005).
5. V. V. McLaughlin, A. Shillington, and S. Rich. Survival in primary pulmonary hypertension—the impact of epoprostenol therapy. Circulation 106:1477–1482 (2002).
Cited by
80 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献